Abstract
The CO-releasing properties of iron(0)tricarbonyl complexes bearing a 2-pyrone ligand have been evaluated. In this report, we demonstrate that the intrinsic stability of the (eta(4)-2-pyrone)Fe(CO)(3) Complex influences the extent and rate of CO release, which is affected by the presence of a halogen substituent on the 2-pyrone ring. The cell viability index has been highlighted for the active carbon monoxide-releasing molecules (CO-RMs), demonstrating that these complexes and related derivatives are a promising new class of compounds with potential therapeutic applications. (c) 2005 Elsevier Ltd. All rights reserved.
Original language | English |
---|---|
Pages (from-to) | 995-998 |
Number of pages | 4 |
Journal | Bioorganic & Medicinal Chemistry Letters |
Volume | 16 |
Issue number | 4 |
DOIs | |
Publication status | Published - 15 Feb 2006 |
Keywords
- vasorelaxation
- carbon monoxide
- transiton metal carbonyl complexes
- therapeutic agents
- CARBON-MONOXIDE
- HEME OXYGENASE-1
- CHOLESTEROL ESTERASE
- IN-VIVO
- 2-PYRONES
- PATHWAY